乞丐 发表于 2025-3-23 12:07:20

http://reply.papertrans.cn/19/1879/187812/187812_11.png

违反 发表于 2025-3-23 13:59:15

http://reply.papertrans.cn/19/1879/187812/187812_12.png

为宠爱 发表于 2025-3-23 19:09:41

http://reply.papertrans.cn/19/1879/187812/187812_13.png

Muffle 发表于 2025-3-23 22:29:39

http://reply.papertrans.cn/19/1879/187812/187812_14.png

Feckless 发表于 2025-3-24 04:07:39

http://reply.papertrans.cn/19/1879/187812/187812_15.png

Aesthete 发表于 2025-3-24 08:30:44

Day-by-Day Home Blood Pressure Monitoring as a Biomarker in Diabetes,have been associated with target organ damage and cardiovascular disease (CVD) risk independent of office blood pressure (OBP). Although hypertension is an important risk factor for diabetic kidney disease (DKD), data are sparse regarding the association between HBP or HBPV and DKD. The J-HOP study

theta-waves 发表于 2025-3-24 14:10:57

Engulfment and Cell Motility Protein (ELMO)-1 as a Biomarker in Type II Diabetes,o monitoring the progression of DN know has been challenging due to its ability to detect early renal lesions, monitoring the progression of renal lesion and treatment to prevent ESRD. Discover novel biomarker performed recently to focus on finding ideal marker of a cellular process that can reflect

食草 发表于 2025-3-24 17:36:25

http://reply.papertrans.cn/19/1879/187812/187812_18.png

Hyaluronic-Acid 发表于 2025-3-24 19:17:53

http://reply.papertrans.cn/19/1879/187812/187812_19.png

fringe 发表于 2025-3-25 00:04:54

http://reply.papertrans.cn/19/1879/187812/187812_20.png
页: 1 [2] 3 4 5 6 7
查看完整版本: Titlebook: Biomarkers in Diabetes; Vinood B. Patel,Victor R. Preedy Living reference work 20220th edition Type 2 Diabetes.insulin action.glycaemic m